Martin R. Jefson,John A. Lowe, III,Fabian Dey,Andreas Bergmann,Andreas Schoop
申请号：
US15741609
公开号：
US10421756B2
申请日:
2016.07.05
申请国别(地区):
US
年份:
2019
代理人:
摘要：
This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula (I) or any one of Compounds 100-175) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.
